ePT--the Electronic Newsletter of Pharmaceutical Technology, Oct 4, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Oct 4, 2012
News
US Science Advisors Issue Report on Innovation in Drug Discovery and Development
By Amy Ritter
The President's Council of Advisors on Science and Technology (PCAST) released a report containing recommendations for boosting innovation in drug discovery and development.
Merck Serono Launches New Spin-off Company; Provides Update on Restructuring
By Patricia Van Arnum
Merck Serono's Asceneuron is the third company to be spun off from the company's Entrepreneur Partnership Program that was launched to mitigate the impact from recent restructuring at its Geneva site.
EMA Aims to Facilitate Biosimilars Development
By Stephanie Sutton
The European Medicines Agency has updated its guidance on biosimilar medicines, with the aim of helping companies to avoid unnecessary repetition of clinical trials.
Week of October 1, 2012: Merck Returns Brinavess Rights to Cardiome; Sigma-Aldrich Expands in Scotland; and More
Merck Returns Brinavess Rights to Cardiome; Sigma-Aldrich Expands in Scotland; and More.
Regulatory Roundup: Week of October 1, 2012
FDA launches BeSafeRx program and releases guidance for industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here